Iodide

Iodide

SCHEMBL4440818

C[N+](C)(C)N.Nc1ccc(Cl)c(Oc2cc(Cl)cc(Br)c2Cl)c1[N+](=O)[O-].[I-]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.33
TSHR P16473 2/20 0.33
EPAS1 Q99814 2/20 0.32
VEGFA P15692 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
PDE7A Q13946 1/20 0.32
HTT P42858 1/20 0.31
TDP1 Q9NUW8 2/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2884549 0.93 ALDH1A1 (0.37) ALDH1A1TSHREPAS1VEGFAMEN1
Iodide SCHEMBL4440824 0.80 ALDH1A1 (0.31) ALDH1A1TSHREPAS1VEGFA
SCHEMBL2880917 0.74 TSHR (0.32) TSHRCYP3A4
SCHEMBL2943368 0.73 MEN1 (0.38) ALDH1A1TSHREPAS1VEGFAMEN1
SCHEMBL2878659 0.72 ALDH1A1 (0.47) ALDH1A1TSHRMEN1KMT2APDE7A
SCHEMBL4786052 0.70 MEN1 (0.36) ALDH1A1TSHREPAS1VEGFAMEN1
SCHEMBL3033748 0.65 EPAS1 (0.34) EPAS1
SCHEMBL22326087 0.65 PDE7A (0.42) ALDH1A1MEN1KMT2APDE7AHTT
SCHEMBL15774527 0.64 HTT (0.46) ALDH1A1TSHRMEN1KMT2AHTT
SCHEMBL22325952 0.64 EPAS1 (0.46) ALDH1A1EPAS1MEN1KMT2APDE7A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121638-A2 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS Merck & Co., Inc. (US) 2009-11-25 EP disclosed
WO-2008076225-A2 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS MERCK & CO., INC. (US) 2008-06-26 WO disclosed